Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis

[1]  Xuelei Ma,et al.  Prognostic role of caveolin in breast cancer: a meta-analysis. , 2013, Breast.

[2]  H. Lee,et al.  Caveolin 1 Expression Correlates with Poor Prognosis and Focal Adhesion Kinase Expression in Gastric Cancer , 2012, Pathobiology.

[3]  M. Toi,et al.  Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer , 2012, Medical Oncology.

[4]  Li-ke Yu,et al.  Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas , 2011, Oncology reports.

[5]  V. Adam,et al.  Caveolin-1 as a potential high-risk prostate cancer biomarker. , 2011, Oncology reports.

[6]  J. Serth,et al.  Caveolin 1 protein expression in renal cell carcinoma predicts survival , 2011, BMC urology.

[7]  F. Sotgia,et al.  Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment , 2011, Breast Cancer Research.

[8]  Hong Chen,et al.  Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma. , 2011, Oncology reports.

[9]  L. Roncuzzi,et al.  499 Metastatic lung cancer proliferation is inhibited by Caveolin-1 silencing , 2010 .

[10]  L. Diao,et al.  Caveolin-1 and VEGF-C promote Lymph Node Metastasis in the Absence of Intratumoral Lymphangiogenesis in Non-small Cell Lung Cancer , 2010, Tumori.

[11]  Jun-quan Yang,et al.  [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer]. , 2008, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[12]  Y. Fujii,et al.  The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. , 2007, Oncology reports.

[13]  Juanhan Yu,et al.  [Significance of caveolin-1 expression in primary lung cancer]. , 2006, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[14]  K. Moon,et al.  Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. , 2005, Anticancer research.

[15]  M. Lisanti,et al.  Caveolin-1 in oncogenic transformation, cancer, and metastasis. , 2005, American journal of physiology. Cell physiology.

[16]  S. Okushiba,et al.  Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma. , 2004, Cancer letters.

[17]  Yoon-La Choi,et al.  Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. , 2003, Lung cancer.

[18]  J. Minna,et al.  P-295 Dramatically different roles for caveolin-1 in the development of Non-Small Cell Lung Cancer (NSCLC) vs. Small Cell Lung Cancer (SCLC) , 2003 .

[19]  Pan‐Chyr Yang,et al.  Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. , 2002, The American journal of pathology.

[20]  S. Woodman,et al.  Caveolae: From Cell Biology to Animal Physiology , 2002, Pharmacological Reviews.

[21]  R. Cardiff,et al.  Mammary Disease Mice Model Premalignant Polyoma Middle-T Transgenic Updated Version , 2001 .

[22]  M. Lisanti,et al.  Caveolin-1 Binding to Endoplasmic Reticulum Membranes and Entry into the Regulated Secretory Pathway Are Regulated by Serine Phosphorylation , 2001, The Journal of Biological Chemistry.

[23]  A. Quest,et al.  Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. , 2000, Cancer research.

[24]  C. Londos,et al.  The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets. , 2000, Biochimica et biophysica acta.

[25]  M. Parmar,et al.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.

[26]  J. Engelman,et al.  Targeted downregulation of caveolin‐1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade , 1998, The EMBO journal.

[27]  J. Engelman,et al.  Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo , 1998, FEBS letters.

[28]  D. Bostwick,et al.  A molecular cytogenetic analysis of 7q31 in prostate cancer. , 1997, Cancer research.

[29]  Charles C. Wykoff,et al.  Recombinant Expression of Caveolin-1 in Oncogenically Transformed Cells Abrogates Anchorage-independent Growth* , 1997, The Journal of Biological Chemistry.

[30]  S. S. Koh,et al.  Baculovirus-based Expression of Mammalian Caveolin in Sf21 Insect Cells , 1996, The Journal of Biological Chemistry.

[31]  M. Lisanti,et al.  Co-purification and Direct Interaction of Ras with Caveolin, an Integral Membrane Protein of Caveolae Microdomains , 1996, The Journal of Biological Chemistry.

[32]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[33]  R. F. Cook,et al.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease , 1994, The Journal of cell biology.

[34]  M. Zheng,et al.  Expression of Caveolin-1 and its significance in the prognosis of lung squamous cell carcinoma , 2013 .

[35]  Chih-Hsin Yang,et al.  Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy. , 2008, Lung cancer.